Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorderActive, not recruitingPhase 1 / Phase 22026-09-30NCT06206837

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Arvinas Estrogen Receptor, Inc.7
Pfizer431

57 results · Page 1 of 3

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Antwerp University HospitalEdegemBelgium16
AZ Groeninge Campus KennedylaanKortrijkBelgium6
BRCR Global - MayagüezMayagüezPuerto Rico1
Clinical and Translational Research Unit (CTRU)Palo AltoUnited States4
Evelyn H. Lauder Breast and Imaging Center (BAIC).New YorkUnited States2
Highlands OncologyFayettevilleUnited States3
Highlands OncologyRogersUnited States4
Highlands Oncology GroupSpringdaleUnited States62
Hoag Health Center IrvineIrvineUnited States6
Hoag Hospital IrvineIrvineUnited States7
Hoag Memorial Hospital PresbyterianNewport BeachUnited States66
Hospital Universitari Vall d'HebronBarcelonaSpain48
Hospital Universitario 12 de OctubreMadridSpain33
Hospital Universitario Arnau de Vilanova de LleidaLleidaSpain6
Hospital Universitario Virgen Del RocioSevilleSpain186
Huntsman Cancer InstituteSalt Lake CityUnited States107
Institut de Cancérologie de l'OuestSaint-HerblainFrance11
Institut Jules BordetAnderlechtBelgium9
Institut Paoli-CalmettesMarseilleFrance9
Institut Régional du Cancer MontpellierMontpellierFrance6
Kanagawa cancer centerYokohamaJapan18
Memorial Sloan Kettering Cancer CenterNew YorkUnited States1000
MSK Basking RidgeBasking RidgeUnited States15
MSK BergenMontvaleUnited States13
MSK CommackCommackUnited States14